These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 33433179)

  • 21. Development and process evaluation of an educational intervention for overdose prevention and naloxone distribution by general practice trainees.
    Klimas J; Egan M; Tobin H; Coleman N; Bury G
    BMC Med Educ; 2015 Nov; 15():206. PubMed ID: 26590066
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Naloxone without the needle - systematic review of candidate routes for non-injectable naloxone for opioid overdose reversal.
    Strang J; McDonald R; Alqurshi A; Royall P; Taylor D; Forbes B
    Drug Alcohol Depend; 2016 Jun; 163():16-23. PubMed ID: 26996745
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Survey of Southern Wisconsin Needle Exchange Clients Regarding Opioid Overdose and Naloxone Use.
    Baltes A; Devo B; Kaiser M; Birstler J; Brown RT
    WMJ; 2019 Jul; 118(2):84-87. PubMed ID: 31532934
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Relay: A Peer-Delivered Emergency Department-Based Response to Nonfatal Opioid Overdose.
    Welch AE; Jeffers A; Allen B; Paone D; Kunins HV
    Am J Public Health; 2019 Oct; 109(10):1392-1395. PubMed ID: 31415200
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Revisiting Naloxone: A different take on overdose guidelines from Lee County, Fla.
    Hamel MG
    JEMS; 2016 Nov; 41(11):46-8. PubMed ID: 29188963
    [No Abstract]   [Full Text] [Related]  

  • 26. Naloxone for Outpatients at Risk of Opioid Overdose #328.
    Chwistek M; Wolf M
    J Palliat Med; 2017 May; 20(5):562-563. PubMed ID: 28296569
    [No Abstract]   [Full Text] [Related]  

  • 27. Naloxone distribution, trauma, and supporting community-based overdose responders.
    Shearer D; Fleming T; Fowler A; Boyd J; McNeil R
    Int J Drug Policy; 2019 Dec; 74():255-256. PubMed ID: 30527865
    [No Abstract]   [Full Text] [Related]  

  • 28. Pharmacokinetic Properties and Human Use Characteristics of an FDA-Approved Intranasal Naloxone Product for the Treatment of Opioid Overdose.
    Krieter P; Chiang N; Gyaw S; Skolnick P; Crystal R; Keegan F; Aker J; Beck M; Harris J
    J Clin Pharmacol; 2016 Oct; 56(10):1243-53. PubMed ID: 27145977
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Naloxone nasal spray.
    Drug Ther Bull; 2019 Sep; 57(9):137-140. PubMed ID: 31296655
    [No Abstract]   [Full Text] [Related]  

  • 30. Rapid widespread distribution of intranasal naloxone for overdose prevention.
    Madah-Amiri D; Clausen T; Lobmaier P
    Drug Alcohol Depend; 2017 Apr; 173():17-23. PubMed ID: 28182982
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Higher naloxone dosing may be required for opioid overdose.
    Bardsley R
    Am J Health Syst Pharm; 2019 Oct; 76(22):1835-1837. PubMed ID: 31665765
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The feasibility of employing a home healthcare model for education and treatment of opioid overdose using a naloxone auto-injector in a private practice pain medicine clinic.
    Dragovich A; Brason F; Beltran T; McCoart A; Plunkett AR
    Curr Med Res Opin; 2018 Dec; 34(12):2137-2141. PubMed ID: 29667452
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Intravenous use of intranasal naloxone: A case of overdose reversal.
    Das S; Shah N; Ghadiali M
    Subst Abus; 2017; 38(1):18-21. PubMed ID: 27925864
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Intranasal naloxone soon to become part of evolving clinical practice around opioid overdose prevention.
    Dietze P; Cantwell K
    Addiction; 2016 Apr; 111(4):584-6. PubMed ID: 26995168
    [No Abstract]   [Full Text] [Related]  

  • 35. Intranasal Naloxone Administration.
    Ortega R; Nozari A; Baker W; Surani S; Edwards M
    N Engl J Med; 2021 Mar; 384(12):e44. PubMed ID: 33761209
    [No Abstract]   [Full Text] [Related]  

  • 36. Rethinking Naloxone: Overdose drug is only one part of the cycle of narcotic abuse.
    Richmond NJ
    JEMS; 2017 Feb; 42(2):63. PubMed ID: 29215840
    [No Abstract]   [Full Text] [Related]  

  • 37. Does take-home naloxone reduce non-fatal overdose?
    Bennett T; Holloway K; Bird SM
    Lancet; 2014 Jan; 383(9912):124-5. PubMed ID: 24411967
    [No Abstract]   [Full Text] [Related]  

  • 38. EVZIO: A New Delivery System for Naloxone.
    Lorman WJ
    J Addict Nurs; 2015; 26(4):217-8. PubMed ID: 26669230
    [No Abstract]   [Full Text] [Related]  

  • 39. Naloxone prescribing: room for finesse.
    Gilham J; Lloyd G
    Br J Hosp Med (Lond); 2019 Mar; 80(3):C46-C48. PubMed ID: 30860915
    [No Abstract]   [Full Text] [Related]  

  • 40. Feasibility of Bystander Administration of Public-Access Naloxone for Opioid Overdose.
    Goldberg SA; Dworkis DA; Liao VT; Eyre AJ; Albert J; Fawcett MM; Narovec CM; DiClemente J; Weiner SG
    Prehosp Emerg Care; 2018; 22(6):788-794. PubMed ID: 29723076
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.